Skip to main content
. 2021 Sep 10;12(5):706–713. doi: 10.4103/idoj.IDOJ_924_20

Table 3.

Mast-cell-mediated symptoms and signs

Symptoms and signs Total (n=66) n (%) MPCM (n=44) n (%) DCM (n=2) n (%) MOS (n=19) n (%) SM (n=1) n (%)
Itching 49 (74.2) 32 (48.4) 2 (100) 14 (73.6) 1 (100)
Recurrent abdominal pain 6 (9.1) 5 (11.3) 0 1 (5.2) 0
Diarrhea 2 (3.0) 1 (2.2) 0 1 (5.2) 0
Headache, dizziness 1 (1.5) 0 0 0 1 (100)
Dyspnea 3 (4.5) 3 (6.8) 0 0 0
Cough, recurrent sinopulmonary infections 1 (1.5) 1 (2.2) 0 0 0
Angioedema 1 (1.5) 0 0 0 1 (100)
Blistering of skin 29 (43.9) 14 (31.8) 2 (100) 12 (63.1) 1 (100)
Darier sign 47 (71.2) 28 (63.6) 2 (100) 16 (84.2) 1 (100)

*Systemic symptoms were reported in 12 patients of whom two had more than one systemic symptom.